Price Alert

Xilio Therapeutics Inc. (XLO)

NASDAQ: XLO · Real-Time Price · USD

0.72

0.02 (2.46%)

At close: Aug 15, 2025, 2:35 PM

2.46% (1D)

Bid	0.72
Market Cap	37.13M
Revenue (ttm)	9.27M
Net Income (ttm)	-54.3M
EPS (ttm)	-0.65
PE Ratio (ttm)	-1.1
Forward PE	-0.83
Analyst	Buy

Ask	0.72
Volume	350,816
Avg. Volume (20D)	575,200
Open	0.71
Previous Close	0.70
Day's Range	0.68 - 0.72
52-Week Range	0.61 - 1.70
Beta	-0.12

About XLO

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol XLO

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for XLO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

New

Xilio Therapeutics has released their quartely earnings on Aug 14, 2025:

Revenue of $8.08M exceeds estimates by $36K, with 242.98% YoY growth.

EPS of -0.16 misses estimates by -0.08, with 33.33% YoY growth.

Next Earnings Release

Xilio Therapeutics Inc. is scheduled to release its earnings on Nov 6, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

-34.57%

Xilio Therapeutics shares are trading lower after ... Unlock content with Pro Subscription

5 months ago

-6.2%

Xilio Therapeutics shares are trading lower. The company reported Q4 financial results.

News

23 hours ago · zacks.com

Xilio Therapeutics, Inc. (XLO) Reports Q2 Loss, Misses Revenue Estimates

Xilio Therapeutics, Inc. (XLO) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.24 per share a year ago.